Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron, vol.25, pp.80886-80893, 2000. ,
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews, N. Engl. J. Med, vol.351, pp.1972-1977, 2004. ,
Chaperone-mediated autophagy markers in Parkinson disease brains, Arch. Neurol, vol.67, pp.1464-1472, 2010. ,
Lysosomal dysfunction increases exosome-mediated alphasynuclein release and transmission, Neurobiol. Dis, vol.42, pp.360-367, 2011. ,
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease, J. Biol. Chem, vol.281, pp.29739-29752, 2006. ,
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease, Mov. Disord, vol.28, pp.811-813, 2013. ,
Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein, Am. J. Hum. Genet, vol.65, pp.555-558, 1999. ,
alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease, Annu. Rev. Cell Dev. Biol, vol.26, pp.211-233, 2010. ,
alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation, Nature, vol.477, pp.107-110, 2011. ,
The regulation of synaptic function by alpha-synuclein, Commun. Integr. Biol, vol.3, pp.106-109, 2010. ,
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease, Nat. Genet, vol.38, pp.515-517, 2006. ,
BAX channel activity mediates lysosomal disruption linked to Parkinson disease, Autophagy, vol.10, pp.889-900, 2014. ,
Lysosomal membrane permeabilization in cell death, Oncogene, vol.27, pp.6434-6451, 2008. ,
Emerging regulation and functions of autophagy, Nat. Cell Biol, vol.15, pp.713-720, 2013. ,
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies, Hum. Mol. Genet, 2014. ,
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet, vol.364, pp.17103-17104, 2004. ,
Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease, Neurogenetics, vol.9, pp.263-269, 2008. ,
Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions, Neurobiol. Dis, vol.35, pp.385-398, 2009. ,
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models, Science, vol.313, pp.324-328, 2006. ,
What genetics tells us about the causes and mechanisms of Parkinson's disease, Physiol. Rev, vol.91, pp.1161-1218, 2011. ,
Direct observation of the interconversion of normal and toxic forms of alpha-synuclein, Cell, vol.149, pp.1048-1059, 2012. ,
Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain, Neurosci. Lett, vol.292, pp.128-130, 2000. ,
Autophagy's top chef, Science, vol.332, pp.1392-1393, 2011. ,
Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy, Science, vol.305, pp.1292-1295, 2004. ,
TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity, Proc. Natl. Acad. Sci. U S A, vol.110, pp.1817-1826, 2013. ,
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue, Biochem. J, vol.60, pp.604-617, 1955. ,
Pathogenic lysosomal depletion in Parkinson's disease, J. Neurosci, vol.30, pp.12535-12544, 2010. ,
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration, Proc. Natl. Acad. Sci. U S A, vol.109, pp.9611-9616, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01290058
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease, Neurology, vol.68, pp.1557-1562, 2007. ,
Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein, J. Biol. Chem, vol.281, pp.9919-9924, 2006. ,
Understanding aging: revealing order out of chaos, Biochim. Biophys. Acta, vol.1658, pp.122-132, 2004. ,
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease, Ann. Hum. Genet, vol.74, pp.97-109, 2010. ,
Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival, J. Neurosci, vol.30, pp.6838-6851, 2010. ,
Doctor Jekyll and Mister Hyde: autophagy can promote both cell survival and cell death, Cell Death Differ, vol.12, pp.1468-1472, 2005. ,
The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy, Mol. Cell, vol.38, pp.265-279, 2010. ,
Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis, PLoS One, vol.8, p.62143, 2013. ,
alpha-Synuclein is phosphorylated in synucleinopathy lesions, Nat. Cell Biol, vol.4, pp.160-164, 2002. ,
Oxidative damage linked to neurodegeneration by selective alphasynuclein nitration in synucleinopathy lesions, Science, vol.290, pp.985-989, 2000. ,
The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis, Proc. Natl. Acad. Sci. U S A, vol.105, pp.145-150, 2008. ,
100 years of Lewy pathology, Nat. Rev. Neurol, vol.9, pp.13-24, 2013. ,
Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders, Acta Neuropathol, vol.120, pp.641-649, 2010. ,
alpha-Synuclein is localized to mitochondria-associated ER membranes, J. Neurosci, vol.34, pp.249-259, 2014. ,
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells, J. Clin. Invest, vol.121, pp.715-725, 2011. ,
DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function, Proc. Natl. Acad. Sci. U S A, vol.107, pp.9747-9752, 2010. ,
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies, Lancet, vol.377, issue.10, pp.62345-62353, 2011. ,
Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha-and beta-synucleins, Biochemistry, vol.37, pp.4901-4909, 1998. ,
Aberrant molecular properties shared by familial Parkinson's disease-associated mutant UCH-L1 and carbonyl-modified UCH-L1, Hum. Mol. Genet, vol.17, pp.1482-1496, 2008. ,
Lysosomal membrane permeabilization during apoptosisinvolvement of Bax?, Int. J. Exp. Pathol, vol.86, pp.309-321, 2005. ,
The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease, Clin. Genet, vol.71, pp.471-473, 2007. ,
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat. Genet, vol.18, pp.106-108, 1998. ,
Sumoylation inhibits alpha-synuclein aggregation and toxicity, J. Cell Biol, vol.194, pp.49-60, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02193319
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target, Nat. Rev. Neurosci, vol.14, pp.38-48, 2013. ,
Intravesicular localization and exocytosis of alpha-synuclein and its aggregates, J. Neurosci, vol.25, pp.6016-6024, 2005. ,
G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome, Ann. Neurol, vol.73, pp.459-471, 2013. ,
Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases, Cell Calcium, vol.50, pp.200-205, 2011. ,
Pathological alpha-synuclein transmission initiates Parkinsonlike neurodegeneration in nontransgenic mice, Science, vol.338, pp.949-953, 2012. ,
Lysosomes: fusion and function, Nat. Rev. Mol. Cell Biol, vol.8, pp.622-632, 2007. ,
Lysosomal degradation of alpha-synuclein in vivo, J. Biol. Chem, vol.285, pp.13621-13629, 2010. ,
Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease, J. Neurosci, vol.30, pp.1166-1175, 2010. ,
Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death, J. Neurosci, vol.26, pp.41-50, 2006. ,
Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy, J. Clin. Invest, vol.118, pp.777-788, 2008. ,
Alpha-synuclein and protein degradation pathways in Parkinson's disease: a pathological feed-back loop, Exp. Neurol, vol.247, pp.308-313, 2013. ,
Ageing and neuronal vulnerability, Nat. Rev. Neurosci, vol.7, pp.278-294, 2006. ,
Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, vol.146, pp.37-52, 2011. ,
An ERcentric view of Parkinson's disease, Trends Mol. Med, vol.19, pp.165-175, 2013. ,
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein, J. Biol. Chem, vol.286, pp.20710-20726, 2011. ,
Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications, J. Biol. Chem, vol.278, pp.27230-27240, 2003. ,
Interplay of LRRK2 with chaperone-mediated autophagy, Nat. Neurosci, vol.16, pp.394-406, 2013. ,
A novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology, Neurobiol. Aging, vol.35, 2014. ,
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science, vol.276, pp.2045-2047, 1997. ,
A novel alpha-synuclein missense mutation in Parkinson disease, Neurology, vol.80, pp.1062-1064, 2013. ,
A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction, Parkinsonism Relat. Disord, vol.15, pp.627-632, 2009. ,
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase, Nat. Genet, vol.38, pp.1184-1191, 2006. ,
Lewy body extracts from Parkinson disease brains trigger alphasynuclein pathology and neurodegeneration in mice and monkeys, Ann. Neurol, vol.75, pp.351-362, 2014. ,
Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells, J. Cell Biol, vol.137, pp.93-104, 1997. ,
Molecular and cellular basis of lysosomal transmembrane protein dysfunction, Biochim. Biophys. Acta, vol.1793, pp.636-649, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00415318
Lysosomal membrane proteins: life between acid and neutral conditions, Biochem. Soc. Trans, vol.38, pp.1420-1423, 2010. ,
Mitochondrial complex I deficiency in Parkinson's disease, Lancet, vol.1, p.1269, 1989. ,
Integral and associated lysosomal membrane proteins, Traffic, vol.8, pp.1676-1686, 2007. ,
Signals from the lysosome: a control centre for cellular clearance and energy metabolism, Nat. Rev. Mol. Cell Biol, vol.14, pp.283-296, 2013. ,
A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB, EMBO J, vol.31, pp.1095-1108, 2012. ,
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease, N. Engl. J. Med, vol.361, pp.1651-1661, 2009. ,
Genome-wide association study reveals genetic risk underlying Parkinson's disease, Nat. Genet, vol.41, pp.1308-1312, 2009. ,
alpha-Synuclein locus triplication causes Parkinson's disease, Science, vol.302, p.841, 2003. ,
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases, J. Neurosci, vol.29, pp.13578-13588, 2009. ,
The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies and multiple system atrophy, 2000. ,
, Ann. N Y Acad. Sci, vol.920, pp.16-27
Alpha-synuclein in Lewy bodies, Nature, vol.388, pp.839-840, 1997. ,
Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation, Ann. Neurol, vol.49, pp.313-319, 2001. ,
alpha-Synuclein oligomers distinctively permeabilize complex model membranes, FEBS J, vol.281, pp.2838-2850, 2014. ,
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders, Am. J. Pathol, vol.152, pp.367-372, 1998. ,
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy, Hum. Mol. Genet, vol.20, pp.40-50, 2011. ,
Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function, J. Biol. Chem, vol.278, pp.44405-44411, 2003. ,
Lysosomal membrane permeabilization in Parkinson disease, Autophagy, vol.7, pp.98-100, 2011. ,
Alpha-Synuclein is degraded by both autophagy and the proteasome, J. Biol. Chem, vol.278, pp.25009-25013, 2003. ,
In vivo demonstration that alpha-synuclein oligomers are toxic, Proc. Natl. Acad. Sci. U S A, vol.108, pp.4194-4199, 2011. ,
Autophagy gone awry in neurodegenerative diseases, Nat. Neurosci, vol.13, pp.805-811, 2010. ,
Boosting chaperone-mediated autophagy in vivo mitigates alpha-synuclein-induced neurodegeneration, Brain, vol.136, pp.2130-2146, 2013. ,
The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration, Neurobiol. Dis, vol.43, pp.17-28, 2011. ,
Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers, FEBS Lett, vol.542, pp.147-152, 2003. ,
Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy, Science, vol.323, pp.124-127, 2009. ,
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann. Neurol, vol.55, pp.164-173, 2004. ,